Alnylam Pharmaceuticals Inc. (ALNY) is a biopharmaceutical company focused on developing RNA interference therapeutics for genetically defined diseases. A mouthful to say -- and above my pay grade in understanding -- but the charts are interesting.
More from Investing
Given there is little price history as yet, things are looking positive so far for sustainable building products firm, AZEK.
With Sino-U.S. relations approaching an all-time low, trade negotiators will chat by video link in an attempt to get the "Phase 1" deal back on track.
The charts of the provider of call center software indicate a longer-term price target well above its current price.
The online payments giant's shares are in an uptrend, but in the short run prices are extended and the stock may be in for some consolidation.